n this episode of the DB Lab podcast, I sit down with Terry O’Regan, a global biotech leader whose career has spanned corporate leadership, industry influence, and breakthrough startup innovation.

Terry was formerly General Manager of Biogen, a leading biotech company focused on neurodegenerative diseases, and also served as Chairman of the industry group. He later moved to the United States, where he led Biogen’s neurology business, a division worth around $7 billion and representing nearly half of the company’s global turnover at the time.

After leading at scale, Terry moved into the startup world, becoming CEO and President of companies focused on autism, epilepsy, and more recently, blood test innovation.

This conversation explores leadership, decision making, navigating complexity, and the importance of putting the real problem on the table. Terry brings a rare mix of global corporate experience and entrepreneurial insight, making this a powerful conversation for anyone interested in leadership, growth, values, conflict, and meaningful innovation.